Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Q Binford who wrote (757)	1/21/2000 6:01:00 PM
From: Dr. John M. de Castro	Read Replies (2) of 1494

I don't expect NTII to initiate a Phase III trial without a partner. The company simply does not have the resources to go this alone. But, with the results that were just announced, I don't believe that NTII will have much trouble signing up a partner. The only issue will be how long it will take. My educated guess is that March or April is the earliest that a deal can be finalized. However, everything always takes longer than you expect in the biotech world. So we may be into summer before the ink is dry. I expect that as soon as all of the analyses are complete on the Phase II data, NTII will begin to design the Phase III. They will talk to the FDA and to their prospective partners and get the design ready, so that once the deal is completed the Phase III can begin soon afterward. This is an exciting time for NTII and us shareholders. The future looks bright and I'm looking forward to watching it unfold. Best regards

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next